Systemic Anticancer Therapy at the End of Life—Changes in Usage Pattern in the Immunotherapy Era-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Systemic Anticancer Therapy at the End of Life—Changes in Usage Pattern in the Immunotherapy Era

Published:2022-12-01 Issue:12 Volume:8 Page:1847
ISSN:2374-2437
Container-title:JAMA Oncology
language:en
Short-container-title:JAMA Oncol

Author:

Canavan Maureen E.¹,Wang Xiaoliang²,Ascha Mustafa S.²,Miksad Rebecca A.²³,Calip Gregory S.²⁴,Gross Cary P.¹,Adelson Kerin B.¹

Affiliation:

1. Yale School of Medicine, New Haven, Connecticut

2. Flatiron Health, Inc, New York, New York

3. Department of Hematology and Oncology, Boston Medical Center, Boston, Massachusetts

4. Center for Pharmacoepidemiology and Pharmacoeconomic Research, University of Illinois Chicago, Chicago

Abstract

This cohort study evaluates the rate of systemic anticancer therapy use among patients dying of cancer.

Publisher

American Medical Association (AMA)

Subject

Oncology,Cancer Research

Link

https://jamanetwork.com/journals/jamaoncology/articlepdf/2797729/jamaoncology_canavan_2022_ld_220029_1670534763.63281.pdf

Reference6 articles.

1. Real-time assessment of resource utilization and subsequent cost analysis in cancer patients (pts) near the end of life (EOL).;McPherson;J Clin Oncol,2018

2. Associations among end-of-life discussions, health-care utilization, and costs in persons with advanced cancer: a systematic review.;Starr;Am J Hosp Palliat Care,2019

3. Early palliative care for patients with metastatic non-small-cell lung cancer.;Temel;N Engl J Med,2010

4. Trends in checkpoint inhibitor therapy for advanced urothelial cell carcinoma at the end of life: insights from real-world practice.;Parikh;Oncologist,2019

5. Adoption of immune checkpoint inhibitors and patterns of care at the end of life.;Riaz;JCO Oncol Pract,2020

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Oncologists’ role in end‐of‐life chemotherapy and patient‐centered care;Cancer;2024-08-11

2. Estimating oncologist variability in prescribing systemic cancer therapies to patients in the last 30 days of life;Cancer;2024-07-30

3. Systemic Anticancer Therapy and Overall Survival in Patients With Very Advanced Solid Tumors;JAMA Oncology;2024-07-01

4. Timing of Palliative Care Consultation Impacts End of Life Care Outcomes in Metastatic Non-Small Cell Lung Cancer;Journal of Pain and Symptom Management;2024-07

5. Why and How to Integrate Early Palliative Care Into Cutting-Edge Personalized Cancer Care;American Society of Clinical Oncology Educational Book;2024-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3